We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

9041:TSEKintetsu Group Holdings Co., Ltd. Analysis

Data as of 2026-03-14 - not real-time

¥3,141.00

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

Kintetsu Group is trading at ¥3,141, which sits below the 20‑day SMA of ¥3,253 and the 50‑day SMA of ¥3,227, suggesting short‑term pressure, yet it remains comfortably above the 200‑day SMA of ¥2,991, supporting the overall bullish trend flag. The RSI of 37.7 points to a modest oversold condition, while the MACD shows a bearish divergence, and the stock is hovering near the calculated support level of ¥3,072 with resistance at ¥3,402, implying a potential bounce if buying interest resumes. Volume is on an increasing trend and the Fear‑Greed Index reads 72.9 ("Greed"), indicating market optimism despite the technical softness. Fundamentally, the company appears cheap with a trailing P/E of 12.3 versus an industry average of 29.1 and a P/B of 1.02, while delivering a dividend yield of 1.91% on a modest 21.5% payout ratio, suggesting dividend sustainability. However, the balance sheet is heavily leveraged, reflected in a debt‑to‑equity ratio of 196 and total debt far exceeding cash reserves, which tempers the attractiveness of the valuation. Operating margins are thin (6.6%) and cash flow metrics are reported as zero**, raising concerns about earnings quality. Overall, the stock offers a modest upside of roughly 3.5% per the upside/downside estimate, but investors must weigh the low‑beta defensive profile against the high leverage risk.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price near technical support at ¥3,072
  • RSI indicating oversold conditions
  • Increasing trading volume

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Significant valuation discount to industry P/E
  • Stable dividend yield with low payout ratio
  • Low beta and defensive sector positioning

Long Term

> 3 years
Neutral
Model confidence: 6/10

Key Factors

  • Diversified conglomerate business model
  • Consistent dividend payments
  • High leverage requiring monitoring

Key Metrics & Analysis

Financial Health

Revenue Growth1.70%
Profit Margin2.59%
P/E Ratio12.3
ROE8.52%
ROA2.19%
Debt/Equity196.03
P/B Ratio1.0
Industry P/E29.1

Technical Analysis

TrendBullish
RSI37.7
Support¥3,072.00
Resistance¥3,402.00
MA 20¥3,253.00
MA 50¥3,227.44
MA 200¥2,990.60
MACDBearish
VolumeIncreasing
Fear & Greed Index72.88

Valuation

Target Price¥3,250.00
Upside/Downside3.47%
GradeUndervalued
TypeValue
Dividend Yield1.91%

Risk Assessment

Beta0.20
Volatility18.51%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.